Convergent Finance completed the acquisition of a minority stake in Camlin Fine Sciences for $24m.

Convergent Finance, a private equity firm, completed the acquisition of a minority stake in Camlin Fine Sciences, a chemical company, for $24m. “We are delighted to enter into such a strong partnership with Infinity and Convergent. Especially in such uncertain times, their confidence and investment in our company will not only strengthen our position in Mexico but also reduce our reliance on China. We will also actively invest into expanding our Blends and Health and Wellness businesses which both show huge potential in the coming years. Today, more than ever, there is a heightened awareness for nutrition, food, and feed ingredients, and at Camlin we see an enormous opportunity in providing more such solutions to the consumers. We will also greatly benefit from Convergent’s global network of relationships, strategic insights and operational expertise,” Ashish Dandekar, Camlin Fine Sciences Managing Director.